Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL6009334 | 0.88 | — | — | |
| SCHEMBL9847825 | 0.88 | — | — | |
| SCHEMBL7411365 | 0.88 | — | — | |
| Bromide SCHEMBL9837092 | 0.88 | — | — | |
| SCHEMBL4681983 | 0.88 | ALDH1A1 (0.75) | — | |
| SCHEMBL1319 | 0.87 | — | — | |
| Water SCHEMBL8878056 | 0.80 | ALDH1A1 (0.86) | — | |
| SCHEMBL8715381 | 0.80 | — | — | |
| SCHEMBL9357181 | 0.80 | ALDH1A1 (0.86) | — | |
| SCHEMBL9407011 | 0.80 | ALDH1A1 (0.86) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113454095-B | Acylphosphino-oxygen compound and preparation method thereof | 安庆莱霆光电科技有限公司 | 2023-08-22 | — | — | CN | claimed |
| US-20220106340-A1 | ACYLPHOSPHINE OXIDE COMPOUNDS AND PREPARATION METHODS THEREOF | ANHUI CHICHEM CORPORATION (CN) | 2022-04-07 | — | — | US | claimed |
| EP-3892625-A1 | ACYLPHOSPHINE OXIDE COMPOUND AND PREPARATION METHOD THEREFOR | Anqing Lighting Optoelectronics Technology Co., Ltd (CN) | 2021-10-13 | — | — | EP | claimed |
| CN-113454095-A | Acylphosphinoxide compound and preparation method thereof | 安庆莱霆光电科技有限公司 | 2021-09-28 | — | — | CN | claimed |
| WO-2020113585-A1 | ACYLPHOSPHINE OXIDE COMPOUND AND PREPARATION METHOD THEREFOR | 安庆莱霆光电科技有限公司 | 2020-06-11 | — | — | WO | claimed |
| WO-2012114167-A1 | PROCESSES FOR THE PREPARATION OF GLATIRAMER ACETATE | BIOCON LIMITED (IN) | 2012-08-30 | — | — | WO | claimed |
| CN-102351860-A | Synthesis method of panipenem and intermediates thereof | HUNAN OUYA BIOLOG CO LTD | 2012-02-15 | — | — | CN | claimed |
| CN-102086202-A | Method for quickly preparing cis-octahydropyrrolo[3,2-b]pyrrole | WUXI APP INC | 2011-06-08 | — | — | CN | claimed |
| CN-1151155-C | 1, 5-dihydro-pyrazolo [3, 4-D ] -pyrimidone derivatives | — | 2004-05-26 | — | — | CN | claimed |
| EP-0973774-B1 | 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES | BAYER AG (DE) | 2003-01-22 | — | — | EP | claimed |
| US-6174884-B1 | CARDIOVASCULAR DISORDERS; CEREBROVASCULAR DISEASES; VASCULAR SYSTEM DISORDERS, ESPECIALLY THE PERIPHERAL BLOOD VESSELS; UROGENITAL DISORDERS; HYPOTENSIVE AGENTS; ANTIARRYTHMIA AND -ISCHEMIC AGENTS; PHOSPHODIESTERASE ACTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 2001-01-16 | — | — | US | claimed |
| CN-1255133-A | 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives | BAYER AG (DE) | 2000-05-31 | — | — | CN | claimed |
| EP-4370507-A1 | HYDROGENATED QUINOXALINES | Otsuka Pharmaceutical Co., Ltd. (JP) | 2024-05-22 | — | — | EP | disclosed |
| CN-113454095-B | Acylphosphino-oxygen compound and preparation method thereof | 安庆莱霆光电科技有限公司 | 2023-08-22 | — | — | CN | disclosed |
| WO-2023286768-A1 | HYDROGENATED QUINOXALINES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-01-19 | — | — | WO | disclosed |
| US-20220144813-A1 | SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2022-05-12 | — | — | US | disclosed |
| EP-0504612-A2 | Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them | AMERICAN CYANAMID COMPANY (US) | 1992-09-23 | — | — | EP | disclosed |
| WO-1991017987-A1 | PHENOL AND PYRIDINOL DERIVATIVES AS PHARMACEUTICALS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1991-11-28 | — | — | WO | disclosed |
| CN-1052677-A | 14 alpha, 17 alpha-ethano-16 alpha-hydroxy-estratrienes | SCHERING AG (DE) | 1991-07-03 | — | — | CN | disclosed |
| US-4568673-A | NITROESTRONE ETHERS OR HYDROXY COMPOUNDS; MAMMARY TUMORS | WAYNE STATE UNIVERSITY (US) | 1986-02-04 | — | — | US | disclosed |